These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 34933179)

  • 21. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
    Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
    Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary protocatechuic acid redistributes tight junction proteins by targeting Rho-associated protein kinase to improve intestinal barrier function.
    So BR; Kim S; Jang SH; Kim MJ; Lee JJ; Kim SR; Jung SK
    Food Funct; 2023 May; 14(10):4777-4791. PubMed ID: 37128780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
    Marchelletta RR; Krishnan M; Spalinger MR; Placone TW; Alvarez R; Sayoc-Becerra A; Canale V; Shawki A; Park YS; Bernts LH; Myers S; Tremblay ML; Barrett KE; Krystofiak E; Kachar B; McGovern DP; Weber CR; Hanson EM; Eckmann L; McCole DF
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PGI
    Pochard C; Gonzales J; Bessard A; Mahe MM; Bourreille A; Cenac N; Jarry A; Coron E; Podevin J; Meurette G; Neunlist M; Rolli-Derkinderen M
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1037-1060. PubMed ID: 33971327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mannose ameliorates experimental colitis by protecting intestinal barrier integrity.
    Dong L; Xie J; Wang Y; Jiang H; Chen K; Li D; Wang J; Liu Y; He J; Zhou J; Zhang L; Lu X; Zou X; Wang XY; Wang Q; Chen Z; Zuo D
    Nat Commun; 2022 Aug; 13(1):4804. PubMed ID: 35974017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOX4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through ROS.
    Han C; Sheng Y; Wang J; Zhou X; Li W; Zhang C; Guo L; Yang Y
    Int Immunopharmacol; 2022 Mar; 104():108361. PubMed ID: 34949550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
    Salaga M; Bartoszek A; Binienda A; Krajewska JB; Fabisiak A; Mosińska P; Dziedziczak K; Niewinna K; Talar M; Tarasiuk A; Kordek R; Fichna J
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function.
    Koelink PJ; Gómez-Mellado VE; Duijst S; van Roest M; Meisner S; Ho-Mok KS; Frank S; Appelman BS; Bloemendaal LT; Vogel GF; van de Graaf SFJ; Bosma PJ; Oude Elferink RPJ; Wildenberg ME; Paulusma CC
    J Crohns Colitis; 2024 Aug; 18(7):1134-1146. PubMed ID: 38366839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The function of Sphingosine-1-phosphate receptor 2 (S1PR2) in maintaining intestinal barrier and inducing ulcerative colitis.
    Chen T; Gu K; Lin R; Liu Y; Shan Y
    Bioengineered; 2022 May; 13(5):13703-13717. PubMed ID: 35707833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression.
    Kim MR; Cho SY; Lee HJ; Kim JY; Nguyen UTT; Ha NM; Choi KY; Cha KH; Kim JH; Kim WK; Kang K
    Phytomedicine; 2022 Aug; 103():154209. PubMed ID: 35689901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo.
    Wang Y; Wen R; Liu D; Zhang C; Wang ZA; Du Y
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
    Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice.
    Akbari P; Braber S; Alizadeh A; Verheijden KA; Schoterman MH; Kraneveld AD; Garssen J; Fink-Gremmels J
    J Nutr; 2015 Jul; 145(7):1604-13. PubMed ID: 26019243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient mice.
    Sydora BC; Tavernini MM; Doyle J; Fedorak RN
    Inflamm Bowel Dis; 2006 Aug; 12(8):750-7. PubMed ID: 16917231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of P2Y1R impedes intestinal mucosa repair during colitis.
    Huan Q; Peng J; Chang Y; Zhang Q; Xing T; Jiang D; Chen W; Shen X; Bian Z; Xiao H
    Int J Biol Sci; 2023; 19(14):4360-4375. PubMed ID: 37781034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression.
    Sun X; Yang Q; Rogers CJ; Du M; Zhu MJ
    Cell Death Differ; 2017 May; 24(5):819-831. PubMed ID: 28234358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis.
    Thomas S; Hoxha K; Alexander W; Gilligan J; Dilbarova R; Whittaker K; Kossenkov A; Prendergast GC; Mullin JM
    J Cell Biochem; 2019 Mar; 120(3):4225-4237. PubMed ID: 30269357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.